Naloxone Hydrochloride Injection, Solution
Product Images NDC 71872-7297

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 71872-7297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 04)

FDA Label Image

Naloxone (Naloxone)

Naloxone (Naloxone)
This is a description of a Naloxone Hydrochloride Injection used for intravenous, intramuscular, or subcutaneous use. It comes in a single-dose vial with a concentration of 0.4mg/mL and is designed to be used with aseptic technique. It is recommended to store between 15°C to 30°C with excursions allowed between 25°C to 77°F. This product is made in Taiwan and distributed by Medical Purchasing Solutions in Scottsdale, Arizona. Dosage instructions are available on the insert.*
FDA Label Image

Naloxone1 (Naloxone1)

Naloxone1 (Naloxone1)
This is a product label for a medication with the brand name "K5081-02". The label advises to store the product away from light and to discard any unused portions. It also indicates that the manufacturing date is recorded as "AIN03007." The medication is manufactured for Baxter Healthcare and is intended for intravenous, intramuscular, or subcutaneous use. The label indicates that the medication is provided in a 1 mL single-dose vial, with an expiration date of February 26th, 2021.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.